Healthcare Sector Review: Winning and Losing Stocks

Wall St. Watchdog reveals information about today’s action in the Healthcare (NYSE:XLV) sector:

Gainers (% price change)

  • Pharmaceutical Product (NASDAQ:PPDI): The shares closed at $32.28, up $6.62, or 25.8%, on the day. Its market capitalization is $3.68 billion. About the company: Pharmaceutical Product Development, Inc. (NYSE:PPD) offers drug discovery and development services to pharmaceutical, biotechnology, and medical device companies. The Company conducts pre-clinical programs and phase I to phase IV clinical trials. For approved drugs, PPD offers product launch services, and patient compliance and medical communications programs.
  • The Medicines Company (NASDAQ:MDCO): The shares closed at $16.60, up $1.72, or 11.56%, on the day. Its market capitalization is $896.60 million. About the company: The Medicines Company develops products that improve specialized care. The Company markets Angiomax, an anticoagulant approved in the United States and other countries for use in patients undergoing coronary angioplasty procedures.
  • Emergent BioSolutions Inc (NYSE:EBS): The shares closed at $17.13, up $1.7, or 11.02%, on the day. Its market capitalization is $614.12 million. About the company: Emergent Biosolutions, Inc. develops and produces immunobiotics, pharmaceutical products that assist the body’s immune system to prevent or treat disease. The Company produces a vaccine for anthrax.
  • MELA Sciences, Inc. (NASDAQ:MELA): The shares closed at $4.63, up $0.2, or 4.51%, on the day. Its market capitalization is $116.97 million. About the company: MELA Sciences Inc is a medical device company focused on the design and development of a non-invasive, point-of-care instrument to assist in the early diagnosis of melanoma. The Company’s product features a device that captures images of suspicious pigmented skin lesions and extracts data.
  • Flamel Tech. S.A. (NASDAQ:FLML): The shares closed at $4.22, up $0.05, or 1.2%, on the day. Its market capitalization is $102.73 million. About the company: Flamel Technologies S.A. develops polymer technologies for applications such as drug delivery, biomaterials, and agrochemicals. The Company’s programs include “Micropump” and “Medusa” in drug delivery, and “ColCys” in biomaterial-based medical devices. Flamel builds on its technology platforms to develop other products, such as new materials for opthalmic lens products.

Losers (% price change)

  • Gentiva Health Services (NASDAQ:GTIV): The shares closed at $3.68, down $1.84, or 33.33%, on the day. Its market capitalization is $112.64 million. About the company: Gentiva Health Services, Inc. provides specialty pharmaceutical and home health care services. The company provides products and services for hemophilia and bleeding disorders, growth hormone deficiency, RSV prevention and nutritional support services. Gentiva also provides services for diabetes, cardiovascular conditions, post-surgical care, orthopedic rehabilitation and other diseases.
  • Sangamo Biosciences, Inc. (NASDAQ:SGMO): The shares closed at $3.04, down $1.31, or 30.11%, on the day. Its market capitalization is $159.49 million. About the company: Sangamo BioSciences, Inc. researches and develops transcription factors in the regulation of genes. These transcription factors are the proteins that turn genes on and off and regulate gene expression by recognizing specific DNA sequences.
  • Metabolix, Inc. (NASDAQ:MBLX): The shares closed at $3.54, down $0.84, or 19.18%, on the day. Its market capitalization is $120.65 million. About the company: Metabolix, Inc. produces biobased, biodegradable, natural plastics and chemicals.
  • Insmed Incorporated (NASDAQ:INSMD): The shares closed at $4.31, down $0.77, or 15.16%, on the day. Its market capitalization is $107.03 million. About the company: Insmed Incorporated is a development stage biopharmaceutical company with expertise in proprietary, advanced liposomal technology designed specifically for inhalation lung delivery.
  • Achillion Pharmaceuticals (NASDAQ:ACHN): The shares closed at $4.01, down $0.71, or 15.04%, on the day. Its market capitalization is $279.57 million. About the company: Achillion Pharmaceuticals Inc. is a biopharmaceutical company that discovers and develops solutions for infectious diseases such as HIV, hepatitis, and resistant bacterial infections.

(Note: Selected financial data are sourced from Google Finance. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>